Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Gonadorelin

GnRH Analog, The Compounded Fertility Adjunct in TRT

Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
FDA-approved gonadorelin products discontinued; now mainly compounded

Reference only. Not medical advice.

What can go wrong

Given TRT-driven axis suppression, gonadorelin's real-world efficacy for fertility preservation on TRT is less rigorously established than pulsatile GnRH's proven role in congenital hypogonadotropic hypogonadism. Compounded products vary in quality. Continuous (non-pulsatile) exposure can suppress rather than stimulate the axis. It does not by itself prevent all TRT effects on fertility.

This is something to take to a clinician. The Atlas can tell you what is known about gonadorelin in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Gonadorelin is a synthetic decapeptide identical to hypothalamic gonadotropin-releasing hormone (GnRH). Delivered in a pulsatile fashion, it stimulates the pituitary to release LH and FSH, supporting testicular testosterone production and spermatogenesis. On TRT it is used to preserve testicular size, intratesticular testosterone, and fertility. After FDA-approved gonadorelin products were discontinued and the U.S. hCG supply tightened, compounded gonadorelin surged across telehealth TRT clinics as the go-to 'hCG alternative.'

The clinic-friendly hCG stand-in for preserving testicular function on TRT.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Preserving testicular size on TRT
  • Maintaining intratesticular testosterone
  • Fertility preservation adjunct
  • hCG alternative in TRT protocols

How it is supposed to work

Gonadorelin binds pituitary GnRH receptors. Because native GnRH is secreted in pulses, pulsatile gonadorelin drives LH/FSH release and downstream testicular function; by contrast, continuous GnRH exposure paradoxically desensitizes and suppresses the axis (the basis of GnRH-agonist therapy in prostate cancer). Its very short half-life is central to how it must be dosed.

Upstream stimulation vs. hCG's direct signal

hCG acts directly on testicular LH receptors, bypassing the hypothalamus and pituitary; gonadorelin instead stimulates the pituitary to make the body's own LH and FSH, more closely mimicking natural signaling and driving both testosterone and FSH-dependent spermatogenesis. In practice its short half-life forces frequent injections, and TRT clinics often use it two to three times daily rather than the every-90-minute pump used in formal fertility medicine.

What it does to fertility

Used specifically to mitigate TRT's suppression of intratesticular testosterone and spermatogenesis. Pulsatile GnRH can achieve fertility outcomes comparable to hCG+FSH in congenital hypogonadotropic hypogonadism; its efficacy as a low-frequency TRT adjunct is more plausibly supportive than fully proven.

What people get wrong

  • Often said'Gonadorelin works just like hCG.'

    ActuallyIt acts upstream on the pituitary rather than directly on the testis, and its very short half-life and TRT-context efficacy differ from hCG; the two are not interchangeable in mechanism or evidence.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

The market for this

What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.

Predominantly compounded through pharmacies serving telehealth TRT clinics; quality depends on the compounder.

At a glance

Amino acids
10 (identical to native GnRH)
Half-life
Very short (minutes)
Ideal delivery
Pulsatile (natural rhythm)
TRT use
Preserve testicular function/fertility

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Gonadorelin. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Pulsatile GnRH in congenital hypogonadotropic hypogonadismMultiple decades

    Restores LH/FSH and can achieve fertility comparable to hCG+FSH, the strongest evidence base, in a different population than TRT users